Title : Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A-status in liver transplant recipients.

Pub. Date : 2021 Apr

PMID : 32986876






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIMS: Donor"s CYP3A-status (CYP3A5 genotype and CYP3A4 expression) can provide prognostic information regarding tacrolimus-metabolizing capacity of the liver graft and initial tacrolimus dosing for therapeutic blood concentrations in liver transplants. Tacrolimus cytochrome P450 family 3 subfamily A member 5 Homo sapiens
2 AIMS: Donor"s CYP3A-status (CYP3A5 genotype and CYP3A4 expression) can provide prognostic information regarding tacrolimus-metabolizing capacity of the liver graft and initial tacrolimus dosing for therapeutic blood concentrations in liver transplants. Tacrolimus cytochrome P450 family 3 subfamily A member 5 Homo sapiens